BridgeBio Oncology Therapeutics, Inc. (BBOT)
Market Closed
30 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
8. 50
+0.27
+3.218%
$
700.94M Market Cap
- P/E Ratio
- Div Yield
292,214 Volume
- Eps
$ 8.23
Previous Close 
Want to track BBOT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BridgeBio Oncology Therapeutics, Inc. (BBOT) Statistics
Valuation metrics
Market Cap 700.94M
Enterprise value 656.53M
Trailing P/E (ttm) -1.54
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) -
Price/Book (mrq) 0.74
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.91
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 185.79K
Average volume (90 days) 347.11K
Price summary
52-Week low 7
52-Week high 14.87
Beta -
50-Day moving average 7.79
200-Day moving average 9.75
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.37%
Return on equity -0.61%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.95
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.1
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 6.16%
Book value per share (mrq) 11.95
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
